These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32592853)

  • 1. Effect of concomitant deep venous reflux on truncal endovenous ablation outcomes in the Vascular Quality Initiative.
    Brown CS; Osborne NH; Kim GY; Sutzko DC; Wakefield TW; Obi AT; Henke PK
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):361-368.e3. PubMed ID: 32592853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of unilateral vs bilateral and staged bilateral vs concurrent bilateral truncal endovenous ablation in the Vascular Quality Initiative.
    Brown CS; Osborne NH; Kim GY; Sutzko DC; Wakefield TW; Obi AT; Koleilat I
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):113-121.e3. PubMed ID: 32470615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after truncal ablation with or without concomitant phlebectomy for isolated symptomatic varicose veins (C2 disease).
    Brown CS; Obi AT; Cronenwett JL; Kabnick L; Wakefield TW; Osborne NH
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):369-376. PubMed ID: 32502731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes.
    Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K;
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women benefit from endovenous ablation with fewer complications: Analysis of the Vascular Quality Initiative Varicose Vein Registry.
    Cher BAY; Brown CS; Obi AT; Wakefield TW; Henke PK; Osborne NH
    J Vasc Surg Venous Lymphat Disord; 2022 Nov; 10(6):1229-1237.e2. PubMed ID: 35933108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of endovenous ablation in patients with a history of deep vein thrombosis.
    Chervonski E; Muqri F; Jacobowitz GR; Rockman CB; Maldonado TS; Berland TL; Garg K; Cayne NS; Sadek M
    J Vasc Surg Venous Lymphat Disord; 2024 Sep; 12(5):101898. PubMed ID: 38677553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obese patients with CEAP (clinical, etiology, anatomy, pathophysiology) C2 and C3 disease show enhanced symptom improvement after endovenous thermal ablation.
    Zottola ZR; Geiger JT; Choo GE; Kedwai BJ; Balceniuk MD; Ellis JL; Doyle AJ; Newhall KA
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101873. PubMed ID: 38513798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of endovenous ablation assessment stratified by great saphenous vein size, gender, clinical severity, and patient-reported outcomes.
    Bendix SD; Peterson EL; Kabbani LS; Weaver MR; Lin JC
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):128-136. PubMed ID: 32353593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of deep venous reflux velocity as a determinant of outcome in patients with combined superficial and deep venous reflux treated with endovenous saphenous ablation.
    Marston WA; Brabham VW; Mendes R; Berndt D; Weiner M; Keagy B
    J Vasc Surg; 2008 Aug; 48(2):400-5; discussion 405-6. PubMed ID: 18644484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial venous procedures can be performed safely and effectively in patients with deep venous reflux.
    Li C; Jacobowitz GR; Rockman CB; Maldonado TS; Berland TL; Garg K; Barfield M; Sadek M
    J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):281-292.e1. PubMed ID: 36368475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recanalization of truncal veins following endoluminal ablation.
    Vuoncino M; Harding J; Hedayati N; Kwong M
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101860. PubMed ID: 38428500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and treatment outcomes of patients undergoing endovenous ablation are significantly different between Intersocietal Accreditation Commission-accredited and nonaccredited vein centers.
    Obi AT; Afridi S; Lurie F
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):346-351. PubMed ID: 32721587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response to combination therapy in the treatment of varicose veins.
    Conway RG; Almeida JI; Kabnick L; Wakefield TW; Buchwald AG; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2020 Mar; 8(2):216-223. PubMed ID: 31843482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom improvement after cyanoacrylate glue adhesion and endovenous laser ablation in low-grade CEAP clinical classes.
    Yie K
    J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):360-369.e2. PubMed ID: 34271248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovenous laser ablation: venous outcomes and thrombotic complications are independent of the presence of deep venous insufficiency.
    Knipp BS; Blackburn SA; Bloom JR; Fellows E; Laforge W; Pfeifer JR; Williams DM; Wakefield TW;
    J Vasc Surg; 2008 Dec; 48(6):1538-45. PubMed ID: 18829223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of comparative studies comparing nonthermal versus thermal endovenous ablation in superficial venous incompetence.
    Hassanin A; Aherne TM; Greene G; Boyle E; Egan B; Tierney S; Walsh SR; McHugh S; Aly S
    J Vasc Surg Venous Lymphat Disord; 2019 Nov; 7(6):902-913.e3. PubMed ID: 31627874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial).
    Holewijn S; van Eekeren RRJP; Vahl A; de Vries JPPM; Reijnen MMPJ;
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):364-374. PubMed ID: 31000063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of endovenous ablations in octogenarians, nonagenarians, and centenarians.
    Kibrik P; Chait J; Arustamyan M; Alsheekh A; Rajaee S; Marks N; Hingorani A; Ascher E
    J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):95-99. PubMed ID: 31471274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First 10-month results of the Vascular Quality Initiative Varicose Vein Registry.
    Obi AT; Sutzko DC; Almeida JI; Kabnick L; Cronenwett JL; Osborne NH; Lal BK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):312-320.e2. PubMed ID: 28411696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.